Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice

Biochemical Pharmacology

Volumn 60, Issue 11, 2000, Pages 1729-1734

  Satoh, Masahiko ^a   Shimada, Akinori ^b   Zhang, Baoxu ^a   Tohyama, Chiharu ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Buthionine sulfoximine; Cisplatinum; Glutathione; Knockout mice; Metallothionein; Renal toxicity

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; CREATININE; GLUTATHIONE; METALLOTHIONEIN; NITROGEN; UREA; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETOXIFICATION; FEMALE; HISTOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; GLUTATHIONE; KIDNEY CORTEX; METALLOTHIONEIN; MICE; MICE, KNOCKOUT;

EID: 0034578520     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00478-0     Document Type: Article

References (40)

1. Platinum compounds: A new class of potent antitumor agents
2. Treatment of genitourinary tumors with cis-dichlorodiammineplatinum(II): Experience in 250 patients
3. Platinum nephrotoxicity
4. Mechanism of action of cis-dichlorodiammineplatinum(II)
5. Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA
6. Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys
7. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles
8. Effect of N,N'-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats
9. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers
10. Protective effect of reduced glutathione against cisplatin-induced nephrotoxicity and lethal toxicity
11. A preliminary clinical experience with reduced glutathione as protector against cisplatin-toxicity
12. Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug
13. Protection against cisplatin toxicity by administration of glutathione ester
14. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor
15. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice
16. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice
17. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination
18. 3+-pretreatment in the rat in vivo and in vitro
19. Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor
20. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor
21. Biochemistry of metallothionein
22. Protective role of metallothionein in renal toxicity of cisplatinum
23. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity
24. Role of metallothionein in protection against renal oxidative stress induced by cis-diamminedichloroplatinum (II) in glutathione-depleted mice
25. Inhibitory effect of zinc(II) on free radical lipid peroxidation in erythrocyte membranes
26. The physiological role of zinc as an antioxidant
27. Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats
28. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse
29. Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay
30. Metallothionein null cells have increased sensitivity to anticancer drugs
31. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
32. Differential sensitization of human carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion
33. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity
34. Metallothionein-independent hepatoprotection by zinc and sakuraso-saponin
35. Analysis of the possible protective role of metallothionein in streptozotocin-induced diabetes using metallothionein-null mice
36. Oxygen free radicals and metallothionein
37. Glutathione: An overview of biosynthesis and modulation
38. Circadian periodicity of tissue glutathione and its relationship with lipid peroxidation in rats
39. Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes
40. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide